Vontobel Holding’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $384K | Sell |
|
|||||
|
2025
Q2 | $517K | Sell |
|
|||||
|
2025
Q1 | $1.1M | Buy |
|
|||||
|
2024
Q4 | $1.15M | Sell |
|
|||||
|
2024
Q3 | $1.68M | Buy |
|
|||||
|
2024
Q2 | $1.78M | Buy |
|
|||||
|
2024
Q1 | $1.12M | Buy |
|
|||||
|
2023
Q4 | $802K | Sell |
|
|||||
|
2023
Q3 | $952K | Sell |
|
|||||
|
2023
Q2 | $915K | Sell |
|
|||||
|
2023
Q1 | $1.04M | Buy |
|
|||||
|
2022
Q4 | $382K | Sell |
|
|||||
|
2022
Q3 | $603K | Buy |
|
|||||
|
2022
Q2 | $482K | Sell |
|
|||||
|
2022
Q1 | $3.71M | Buy |
|
|||||
|
2021
Q4 | $1.85M | Buy |
|
|||||
|
2021
Q3 | $1.72M | Sell |
|
|||||
|
2021
Q2 | $1.88M | Buy |
|
|||||
|
2021
Q1 | $1.56M | Sell |
|
|||||
|
2020
Q4 | $2.22M | Buy |
|